Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - iron as iron dextran; vitamin a palmitate; vitamin d3 = cholecalciferol; tocopheryl acetate (vitamin e) - parenteral liquid/solution/suspension - iron as iron dextran mineral-iron active 100.0 mg/ml; vitamin a palmitate vitamin-a other 10000.0 iu/ml; vitamin d3 = cholecalciferol vitamin-d3 other 1000.0 iu/ml; tocopheryl acetate (vitamin e) vitamin-e other 10.0 mg/l - nutrition & metabolism - pig - piglet | neonatal piglet | new born pig | sucker pig - iron supplement

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - deferasirox 125mg;  ;   - dispersible tablet - 125 mg - active: deferasirox 125mg     excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose povidone sodium laurilsulfate - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and paediatric patients (aged 2 years and over).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - deferasirox 250mg;  ;   - dispersible tablet - 250 mg - active: deferasirox 250mg     excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose povidone sodium laurilsulfate - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and paediatric patients (aged 2 years and over).

New Zealand - engelsk - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - deferasirox 500mg;  ;   - dispersible tablet - 500 mg - active: deferasirox 500mg     excipient: colloidal silicon dioxide crospovidone lactose monohydrate magnesium stearate microcrystalline cellulose povidone sodium laurilsulfate - exjade is indicated for the treatment of chronic iron overload due to blood transfusions (transfusional haemosiderosis) in adult and paediatric patients (aged 2 years and over).

Singapore - engelsk - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - deferasirox - tablet, for suspension - 125.0 mg

Singapore - engelsk - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - deferasirox - tablet, for suspension - 250.0 mg

Singapore - engelsk - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - deferasirox - tablet, for suspension - 500.0 mg

Canada - engelsk - Health Canada

pfizer canada ulc - deferoxamine mesylate - powder for solution - 500mg - deferoxamine mesylate 500mg - heavy metal antagonists

Canada - engelsk - Health Canada

pharmascience inc - deferoxamine mesylate - powder for solution - 500mg - deferoxamine mesylate 500mg - heavy metal antagonists

Canada - engelsk - Health Canada

pharmascience inc - deferoxamine mesylate - powder for solution - 2g - deferoxamine mesylate 2g - heavy metal antagonists